Member Info for PL75

£10m Bein? What with all the potential of affimers diagnostics?

SB

Look at the thread title. Then you’ll never need to consider what the gambling moronic troll is up to. (Probably trying to recover more losses from buying high and averaging down in another dog)

I’m doing my bit. Anyway, the standard multiplier is 8.9x, Rah said so

If anyone wants to see my toe nails, let me know.

They're planning a science day. They have an investormeet with a Q&A. They've released the Spotlight Series for the layman. Comms are fine and the poster was perfectly understandable.

Why would anyone be investing at this early stage if they didn't have a grasp of what they're trying to achieve and the science. They're a small biotech on aim, the popularity is only due to covid, otherwise they wouldn't be on anyone's radar. Joe public investors will rock up when ava6k is bringing in billions and there are PE ratios they can understand. That's quite the advantageous position for early investors to be in.

If anyone sold today based on an article in German written by a corrupt moron... More fool them. No impact for me, other than a reduced 'top up' price.

Spot on cindercone. It's a rinse / repeat of last time. Can't believe it's being taken seriously by anyone.

RD, Cuddon tie his shoelaces nonsense available here:

https://de.investing.com/news/stock-market-news/avacta-enttauscht-bei-phase1studie--deutsche-bank-stuft-aktie-auf-sell-herab-2706637

WAG, spot on, the corrupt connection was called out previously. It was published in a dusty corner of t'internet in German, yet popped up here in minutes. Utter Scum. They must want out of their short.

The safety results were exceptional. They were boshing in killer amounts every other week and not a single AE. As it happens, given the population, the efficacy results were equally exceptional. Stable disease or improvement in the vast majority. Not bad at all.... Shame that shameless moron Cuddon understand the data. (I will continue to place Cuddon in place of couldn't as a pun whether you like it or not)

Weird that the earlier thread was removed. It was discussed and laughed at before market open - I guess they didn't want that on here. I'm mainly upset as my Cuddon pun has gone.

It's badly researched nonsense on a par with motley clowns. The hatred for a business aiming to relieve the suffering of cancer victims goes way beyond bizarre. Whatever, the negative spam clearly isn't going to stop. I've kept some powder dry, so I'll take advantage again.

What's the difficulty in taking over a company that's done licence deals. They just honour the deals. They're contracts. No issue at all

I can't believe she was there. After the stick she got for not being chained to her London desk and having a holiday recently. She should know better and be sat at her desk, ink pot nearby waiting for the flurry of calls from big farmer wanting a piece of the action.

I just posted a lot yesterday. Nice to have something new to discuss.

What I won’t discuss is when the masterplan comes together. Just wait.

Posted this yesterday:

I’m expecting an RNS on Monday saying the presentation is on the website with an update just casually dropping in that that they’re now in the expansion phase. Seems to be CCs style and I like it. All milestones on track for H2.

The milestones slide from the AGM doesn’t have dates on, but it does have lines looking a lot like they represent quarters indicating moving on to 1b in Q4 running to mid 25. So ending 1a now is bang on time. Soon find out, or they’ll wait until the investormeet to update.

It was mentioned previously at the science day by Elliot, but not explicitly published on a poster at a conference

Posted this yesterday:

Looks like we’re in the expansion phase and they’ve seen all they needed to. The trial design graphic is cut short. Final sentence:

The study continues with recommended dose for expansion cohorts.

They’ve chosen their indications. Phase 1a is over folks.

Posted this last night...

Disease progression in only 7 out of them all. Given the selection criteria, that’s amazing. Progression free survival rates look remarkable. 8 fap high patients are still receiving treatment. PFS and quality of life can be considered for accelerated approval. Looks nailed on with these results.

Market forces would stop it. The BoD wouldn’t recommend it, the price would go through the roof, bidding wars would ensue and if all all else fails, a poison pill. Tell you what, I’ll buy your shares for 150p after a bid comes in.

I think that was meant to say "There’s absolutely no possible way that BP wouldn’t be unlikely to not avoid in no way being unable to not refrain from never failing to not be all over this by now, is there not?"

Oh ok Bella. Silly me. You constantly post sh.t, it’s very difficult to tell

¯\_(ツ)_/¯

Absolutely. I know when I'm deciding whether to 'top up' I always take a look at how LSE have recorded buys and sells. Crucial stuff.